Us TOO Logo
Search
  1. Hot Sheets 2007- UsToo Internationl
Subscribe to Get Prostate Cancer News

Subscribe

HotSheets by Year

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001

HotSheets 2007

January February March April May June July August September October November December
January | Newsletter
  • President’s Message: Taking Action in 2007
  • Feb Conf Call: "Intimacy & Prostate Cancer"
  • Companies, Chapters Signing Up for Sneakers@Work Day
  • New Tests of Dendreon’s Prostate Cancer
  • Doc Moyad’s What Works and What is Worthless Column: Vitamin D—Part II
  • Read more..
February | Newsletter
  • President’s Message: “What Is Awareness?
  • Special Thanks to Joe Piper
  • The Year in Prostate Cancer: Part I of II
  • Doc Moyad’s What Works and What is Worthless Column: Vitamin D—Part III
  • Feb. 13th Conference Call:
    Intimacy & Prostate Cancer
  • 2nd Annual Us TOO Online Auction
    Announced, Seeking Donated Items for Bid
  • Read more..
March | Newsletter
  • Survivor Rate Highest with Prostatectomy for Localized Prostate Cancer
  • New Members for Us TOO Board of Directors
  • The Year in Prostate Cancer, Part II
  • Medicare Part D and Erectile Dysfunction
  • Leading by Example
  • PROVENGE® Granted FDA Priority Review
  • Read more..
April | Newsletter
  • Special Burning Issues Supplement: Highlights from the 2007 Multidisciplinary Prostate Cancer Symposium - February 21-24, 2007, Orlando, FL
  • GPC Biotech Provides Satraplatin for Free
  • Calcitriol with Docetaxel Boosts Survival
  • The Year in Prostate Cancer - Part 3
  • Estrogen Therapy: DES (Diethylstilbestrol)
  • Doc Moyad’s What Works and What is Worthless Column: Zinc supplementation?
  • Read more..
May | Newsletter
  • Special Burning Issues Supplement: Prostate cancer and incontinence: coping strategies and treatment options
  • MRI in Managing Prostate Cancer
  • FDA Panel Backs New Prostate Vaccine
  • Adjuvant ADT Can “Cure” Nonmetastasized Prostate Cancer
  • Alendronate Increases BMD in Prostate Cancer Patients Receiving ADT
  • Doc Moyad’s What Works and What is Worthless Column—Lycopene
  • Read more..
June | Newsletter
  • Doc Moyad’s What Works and What is Worthless Column—Provenge®
  • Cell Genesis Reports Phase II Results with GVAX Immunotherapy
  • A Survivor Reviews the 2007 ASCO Prostate Cancer Symposium
  • UCSD Researchers Report Ability to Detect Cancer at Earliest, Curable Stage
  • New Blood Test for Prostate Cancer—Can EPCA-2 be on the Horizon?
  • Possible New Cancer Treatment? Antifungal Drug Stops Blood Vessel Growth
  • Read more..
July | Newsletter
  • New AUA Prostate Cancer Guidelines
  • FDA Requirements for Provenge® Licensure
  • Consider Source of Localized Prostate Cancer Recommendations
  • Dendreon Sued after Provenge’s Ok Put Off
  • 223Radium in Hormone-Refractory Cancer
  • Update:Outcomes with Primary Therapy for Intermediate Risk Prostate Cancer
  • Read more..
August | Newsletter
  • New Data from ASCO on SPARC Trial
  • Us TOO University in Austin, Texas “A Marvelous Evening”
  • Survivorship Care Plan Is an Important Part of Cancer Care
  • Sneakers@ Work Day, Great Fun, Great Success
  • F-18 Fluor Choline PET/CT Assesses Bone Metastases in Prostate Cancer
  • New Procedure Minimizes Post-Prostatectomy Incontinence
  • Read more..
September | Newsletter
  • Court Sees No Right to Unapproved Drugs
  • FDA Requests More Data on Satraplatin
  • Hormone Inhibitor Promising For Hard-to-Treat Prostate Cancer
  • FDA Sued Over Provenge Delay
  • Botox for Treating Prostate Problems
  • Doc Moyad’s “No Bogus Science” Column
  • Friday the 13th Lucky for Prostate Pointers
  • Read more..
October | Newsletter
  • CMS Proposal Would Virtually Eliminate Medicare Clinical Trials Coverage
  • Statins Fail to Cut the Androgens that Fuel Prostate Cancer
  • Stress Management before Prostatectomy
  • First Biomarker Discovered that Predicts Prostate Cancer Outcome
  • Prostate Px® Test Results Published
  • Doc Moyad’s What Works and What is Worthless Column
  • Read more..
November | Newsletter
  • Charity Navigator Gives Us TOO 4-Star Rating
  • Gleason Score and Prostate Cancer Prognosis
  • New Study Refutes Belief that Black Men Have More Aggressive Prostate Cancer
  • Us TOO Reaches Out to Federal Employees and Military
  • Nomogram Can Predict Life Expectancy
  • oc Moyad’s What Works and What is Worthless Column—Ginseng
  • Read more..
December | Newsletter
  • Us TOO’s 2006 Annual Report Now Available
  • New Free Kits for Newly-Diagnosed Men
  • Survival Analysis from the SPARC Trial
  • Us TOO University Chicago Program a Success
  • October 30th Intimacy Teleconference a Success
  • Biopsy Site Affects Prostate Cancer Detection
  • Read more..